![](/img/cover-not-exists.png)
Patient-Administered Biologic and Biosimilar Filgrastim May Offer More Affordable Options for Patients with Nonmyeloid Malignancies Receiving Chemotherapy in the United States: A Budget Impact Analysis from the Payer Perspective
Trautman, Holly, Szabo, Erika, James, Elizabeth, Tang, BoxiongLanguage:
english
Journal:
Journal of Managed Care & Specialty Pharmacy
DOI:
10.18553/jmcp.2018.18094
Date:
August, 2018
File:
PDF, 222 KB
english, 2018